Loading...
XNAS
LFWD
Market cap506mUSD
Jul 09, Last price  
8.44USD
1D
3.91%
1Q
28.46%
Jan 2017
-99.86%
IPO
-99.99%
Name

Rewalk Robotics Ltd

Chart & Performance

D1W1MN
XNAS:LFWD chart
P/E
P/S
22.99
EPS
Div Yield, %
Shrs. gr., 5y
-5.94%
Rev. gr., 5y
38.06%
Revenues
22m
-14.14%
972,0001,588,0003,951,0003,746,0005,869,0007,753,0006,545,0004,873,0004,393,0005,966,0005,511,00013,854,00025,663,00022,034,000
Net income
-20m
L
-6,658,000-12,177,000-21,668,000-25,415,000-32,503,000-24,717,000-21,675,000-15,551,000-12,976,000-12,736,000-19,569,000-22,133,000448,000-19,914,000
CFO
-17m
L-22.53%
-5,387,000-8,800,000-15,318,000-25,180,000-27,537,000-22,498,000-14,774,000-14,815,000-12,589,000-11,469,000-17,891,000-20,667,000-21,718,000-16,826,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

ReWalk Robotics Ltd., an Israeli medical technology firm, was founded in 2001 and is headquartered in Yokneam Ilit. The company specializes in the creation and market introduction of robotic exoskeletons. These advanced devices are engineered to support individuals confronting mobility challenges or various other medical conditions across major global markets including the United States, Europe, the Asia-Pacific region, and Africa. Its product line features the ReWalk Personal and ReWalk Rehabilitation systems, designed for daily assistance for paraplegic individuals with spinal cord injuries, enabling their use both at home and within their communities. For clinical rehabilitation of stroke patients with lower limb disabilities, ReStore provides a soft exo-suit. Additionally, ReWalk offers the MyoCycle and MediTouch tutor, biofeedback tools facilitating movement therapy in either home or clinical environments. ReWalk Robotics distributes its innovative solutions directly to diverse clients, including third-party payers, rehabilitation centers and other institutions, and individual users. It also leverages third-party distributors to broaden its reach. The company operated previously under the name Argo Medical Technologies Ltd.
IPO date
Sep 12, 2014
Employees
56
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT